Relay Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.0M | 7.0M | 0 | 677K | 7.7M | 0 | 0 | 0 |
| Cost of Goods Sold | 504K | 599K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 2.5M | 6.4M | 0 | 677K | 7.7M | 0 | 0 | 0 |
| R&D Expenses | 70.6M | 55.4M | 68.3M | 63.9M | 73.8M | 68.1M | 76.6M | 92.0M |
| Operating Expenses | 81.1M | 67.0M | 80.4M | 77.5M | 92.5M | 85.0M | 96.4M | 100.8M |
| Operating Income | -78.6M | -60.6M | -80.4M | -76.8M | -84.9M | -85.0M | -96.4M | -100.8M |
| Other Income / Gains | 5.3M | 5.7M | 6.2M | 6.5M | 7.8M | 9.0M | 8.3M | 8.5M |
| Net Income | -73.3M | -54.9M | -74.1M | -70.4M | -77.1M | -76.0M | -88.1M | -92.2M |
| EPS (Diluted) | -0.41 | -0.32 | -0.43 | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.832 | 0.914 | 0 | 1.00 | 1.00 | 0 | 0 | 0 |
| General And Administrative Expenses | 11.0M | 13.0M | 12.1M | 13.6M | 18.7M | 16.9M | 19.8M | 20.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 11.0M | 13.0M | 12.1M | 13.6M | 18.7M | 16.9M | 19.8M | 20.1M |
| Other Expenses | -504K | -1.3M | 0 | 0 | 0 | 0 | 0 | -11.4M |
| Cost And Expenses | 81.6M | 67.6M | 80.4M | 77.5M | 92.5M | 85.0M | 96.4M | 100.8M |
| Interest Income | 5.4M | 5.7M | 6.4M | 7.1M | 7.8M | 9.0M | 8.3M | 8.5M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 504K | -3.0M | 748K | 1.0M | 1.2M | 1.3M | 1.4M | 1.4M |
| Ebitda | -78.1M | -57.8M | -79.6M | -75.8M | -83.7M | -83.6M | -95.0M | -110.8M |
| Ebitdaratio | -26.029 | -8.264 | 0 | -112.031 | -10.895 | 0 | 0 | 0 |
| Operating Income Ratio | -26.197 | -8.662 | 0 | -113.511 | -11.052 | 0 | 0 | 0 |
| Income Before Tax | -73.3M | -54.9M | -74.1M | -70.4M | -77.1M | -76.0M | -88.1M | -92.2M |
| Income Before Tax Ratio | -24.43 | -7.841 | 0 | -103.951 | -10.036 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -24.43 | -7.841 | 0 | -103.951 | -10.036 | 0 | 0 | 0 |
| Epsdiluted | -0.41 | -0.32 | -0.43 | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 |
| Weighted Average Shs Out | 179.8M | 171.6M | 172.4M | 171.3M | 169.2M | 167.3M | 140.2M | 132.8M |
| Weighted Average Shs Out Dil | 179.8M | 171.6M | 172.4M | 171.3M | 169.2M | 167.3M | 140.2M | 132.8M |